Olga Latinovic

1.5k total citations · 1 hit paper
40 papers, 1.1k citations indexed

About

Olga Latinovic is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Olga Latinovic has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Virology, 20 papers in Infectious Diseases and 13 papers in Immunology. Recurrent topics in Olga Latinovic's work include HIV Research and Treatment (26 papers), HIV/AIDS drug development and treatment (16 papers) and Immune Cell Function and Interaction (9 papers). Olga Latinovic is often cited by papers focused on HIV Research and Treatment (26 papers), HIV/AIDS drug development and treatment (16 papers) and Immune Cell Function and Interaction (9 papers). Olga Latinovic collaborates with scholars based in United States, Italy and Nigeria. Olga Latinovic's co-authors include Gregory B. Melikyan, Kosuke Miyauchi, Yuri Kim, Vladimir A. Morozov, Alonso Heredia, Robert C. Gallo, Marvin S. Reitz, Nhut Le, Robert Redfield and Sabrina Curreli and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Virology.

In The Last Decade

Olga Latinovic

40 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes

2009 524 citations Kosuke Miyauchi, Yuri Kim et al. Cell profile →

Peers

Countries citing papers authored by Olga Latinovic

Since Specialization

Citations

This map shows the geographic impact of Olga Latinovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Latinovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Latinovic more than expected).

Fields of papers citing papers by Olga Latinovic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Latinovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Latinovic. The network helps show where Olga Latinovic may publish in the future.

Co-authorship network of co-authors of Olga Latinovic

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Latinovic. A scholar is included among the top collaborators of Olga Latinovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Latinovic. Olga Latinovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Potential Advantages of a Well-balanced Nutrition Regimen for People Living with Human Immunodeficiency Virus Type -1 2024 ·PubMed ·(unknown), Olga Latinovic, (unknown)	4
2	Identifying CCR5 coreceptor populations permissive for HIV-1 entry and productive infection: implications for in vivo studies 2022 ·Journal of Translational Medicine ·(unknown), Yutaka Tagaya, Marvin S. Reitz, Anthony L. DeVico, Olga Latinovic	10
3	Comparison of SARS-CoV-2 Receptors Expression in Primary Endothelial Cells and Retinoic Acid-Differentiated Human Neuronal Cells 2021 ·Viruses ·Francesca Benedetti, (unknown), Carla Mavian, (unknown), Arshi Munawwar, Melanie N. Cash, (unknown), Amy Y. Vittor, Massimo Ciccozzi, Marco Salemi, Olga Latinovic, Davide Zella	10
4	Combined cART including Tenofovir Disoproxil, Emtricitabine, and Dolutegravir has potent therapeutic effects in HIV-1 infected humanized mice 2021 ·Journal of Translational Medicine ·(unknown), (unknown), Alonso Heredia, (unknown), Mohammad M. Sajadi, (unknown), Yutaka Tagaya, Francesca Benedetti, Habib O. Ramadhani, Frank Denaro, Arshi Munawwar, Joseph Bryant, Davide Zella, Marvin S. Reitz, Fabio Romerio, Olga Latinovic	5
5	Role of Mycoplasma Chaperone DnaK in Cellular Transformation 2020 ·International Journal of Molecular Sciences ·Francesca Benedetti, Fiorenza Cocchi, Olga Latinovic, Sabrina Curreli, Selvi Krishnan, Arshi Munawwar, Robert C. Gallo, Davide Zella	25
6	The HIV-1 Transgenic Rat: Relevance for HIV Noninfectious Comorbidity Research 2020 ·Microorganisms ·Frank Denaro, Francesca Benedetti, (unknown), Giovanni Scapagnini, (unknown), (unknown), Joseph Bryant, Harry Davis, Olga Latinovic, Davide Zella	3
7	Anti-HIV Activity of Standard Combined Antiretroviral Therapy in Primary Cells Is Intensified by CCR5-Targeting Drugs 2020 ·AIDS Research and Human Retroviruses ·(unknown), (unknown), Alonso Heredia, Yutaka Tagaya, Francesca Benedetti, Davide Zella, Marvin S. Reitz, Fabio Romerio, Olga Latinovic	5
8	Cauliflower Mosaic Virus TAV, a Plant Virus Protein That Functions like Ribonuclease H1 and is Cytotoxic to Glioma Cells 2020 ·BioMed Research International ·(unknown), Olga Latinovic, Massimiliano Bonafè, Ngeh J. Toyang, (unknown), (unknown), Pier Luigi Martelli, (unknown), (unknown), Anna Sarnelli, Rita Casadio, Claudio Ratti, Paola Massi, James E. Schoelz, María S. Salvato, Filippo Piccinini, Giovanni Martinelli	2
9	Suppression of Active HIV-1 Infection in CD34 ⁺ Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting Drugs 2019 ·AIDS Research and Human Retroviruses ·Olga Latinovic, (unknown), Yutaka Tagaya, Alonso Heredia, Sandra Medina-Moreno, Juan Carlos Zapata, Marvin S. Reitz, Joseph Bryant, Robert Redfield	8
10	Hijacking antibody-induced CTLA-4 lysosomal degradation for safer and more effective cancer immunotherapy 2019 ·Cell Research ·Yan Zhang, Xuexiang Du, Mingyue Liu, Fei Tang, Peng Zhang, (unknown), James K. Fields, Eric J. Sundberg, Olga Latinovic, Martin Devenport, Pan Zheng, Yang Liu	86
11	Full Length Single Chain Fc Protein (FLSC IgG1) as a Potent Antiviral Therapy Candidate: Implications for In Vivo Studies 2015 ·AIDS Research and Human Retroviruses ·Olga Latinovic, Sandra Medina-Moreno, (unknown), Neelakshi Gohain, Juan Carlos Zapata, Marzena Pazgier, Marvin S. Reitz, Joseph Bryant, Robert Redfield	3
12	Natural killer T (NKT) cells accelerate Shiga toxin type 2 (Stx2) pathology in mice 2015 ·Frontiers in Microbiology ·Fumiko Obata, Priyanka B. Subrahmanyam, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Dakshina M. Jandhyala, Glynis L. Kolling, Olga Latinovic, Tonya J. Webb	4
13	Synergistic Inhibition of R5 HIV-1 by the Fusion Protein (FLSC) IgG1 Fc and Maraviroc in Primary Cells: Implications for Prevention and Treatment 2015 ·Current HIV Research ·Olga Latinovic, Jian Zhang, Yutaka Tagaya, Anthony L. DeVico, Timothy Fouts, (unknown), Joseph R. Lakowicz, Alonso Heredia, Robert R. Redfield	4
14	Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17 2015 ·Pathogens and Disease ·(unknown), Olga Latinovic, Mark K. Lafferty, Lingling Sun, Joseph Bryant, Wuyuan Lu, Francesca Caccuri, Arnaldo Caruso, Robert C. Gallo, Alfredo Garzino‐Demo	13
15	A novel small-molecule inhibitor of HIV-1 entry 2015 ·Drug Design Development and Therapy ·Erik de Leeuw, Alonso Heredia, Olga Latinovic, Florent Barbault	10
16	Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist Maraviroc 2014 ·Antiviral Research ·Olga Latinovic, (unknown), Henryk Szmacinski, Joseph R. Lakowicz, Alonso Heredia, Robert R. Redfield	4
17	HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes breakdown → 2009 ·Cell ·Kosuke Miyauchi, Yuri Kim, Olga Latinovic, Vladimir A. Morozov, Gregory B. Melikyan	524
18	Structural and micromechanical characterization of type I collagen gels 2009 ·Journal of Biomechanics ·Olga Latinovic, Lawrence A. Hough, H. Daniel Ou‐Yang	36
19	Rapamycin enhances aplaviroc anti-HIV activity: Implications for the clinical development of novel CCR5 antagonists 2009 ·Antiviral Research ·Olga Latinovic, Alonso Heredia, Richard L. Gallo, (unknown), Nhut Le, Robert Redfield	13
20	Inhomogeneity of Type I Collagen Gels 2005 ·Bulletin of the American Physical Society ·Olga Latinovic, H. Daniel Ou‐Yang	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact